Tag: Bella Wang
Fangda, MoFo steer USD900m Boomray-Novartis licence agreement
Boomray Pharmaceuticals enters into an exclusive global licence agreement valued at up to USD900 million with Novartis for a preclinical radioligand therapy
Firms act on USD2.5bn US-Korean AI-driven drug discovery pact
Firms assists on US-South Korea AI driven drug discovery collaboration between Insilico Medicine and SK Biopharmaceuticals
S&C assists on TCC concurrent issue of USD804m green bonds, GDS
Sullivan & Cromwell (S&C) has acted for the buyers of TCC issue of green convertible bonds and GDS in the largest such concurrent issuance in Asia in the past two years
